8-K//Current report
Seres Therapeutics, Inc. 8-K
Accession 0001193125-24-226929
$MCRBCIK 0001609809operating
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 4:13 PM ET
Size
166.9 KB
Accession
0001193125-24-226929
Documents
- 8-Kd713439d8k.htmPrimary
8-K
- EX-99.1d713439dex991.htm
EX-99.1
- EX-101.SCHmcrb-20240926.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABmcrb-20240926_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREmcrb-20240926_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-24-226929-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd713439d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001609809
Filing Metadata
- Form type
- 8-K
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 4:13 PM ET
- Size
- 166.9 KB